{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:16:59Z","timestamp":1784143019332,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T00:00:00Z","timestamp":1585612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40120-020-00183-7","type":"journal-article","created":{"date-parts":[[2020,3,31]],"date-time":"2020-03-31T02:02:46Z","timestamp":1585620166000},"page":"135-149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy"],"prefix":"10.1007","volume":"9","author":[{"given":"Alejandra","family":"Gonz\u00e1lez\u2010Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Concei\u00e7\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Amass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc F.","family":"Botteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,31]]},"reference":[{"issue":"1","key":"183_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/jns.12153","volume":"21","author":"I Conceicao","year":"2016","unstructured":"Conceicao I, Gonzalez-Duarte A, Obici L, et al. \u201cRed-flag\u201d symptom clusters in transthyretin familial amyloid polyneuropathy. J Peripher Nerv Syst. 2016;21(1):5\u20139. https:\/\/doi.org\/10.1111\/jns.12153.","journal-title":"J Peripher Nerv Syst"},{"issue":"29","key":"183_CR2","doi-asserted-by":"publisher","first-page":"27207","DOI":"10.1074\/jbc.M101024200","volume":"276","author":"A Quintas","year":"2001","unstructured":"Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem. 2001;276(29):27207\u201313. https:\/\/doi.org\/10.1074\/jbc.M101024200.","journal-title":"J Biol Chem"},{"issue":"12","key":"183_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jcmg.2016.07.008","volume":"9","author":"V Algalarrondo","year":"2016","unstructured":"Algalarrondo V, Antonini T, Th\u00e9audin M, et al. Cardiac dysautonomia predicts long-term survival in hereditary transthyretin amyloidosis after liver\u00a0transplantation. JACC Cardiovasc Imaging. 2016;9(12):1432\u201341. https:\/\/doi.org\/10.1016\/j.jcmg.2016.07.008.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"8","key":"183_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3109\/07853890.2015.1068949","volume":"47","author":"PN Hawkins","year":"2015","unstructured":"Hawkins PN, Ando Y, Dispenzeri A, Gonzalez-Duarte A, Adams D, Suhr OB. Evolving landscape in the management of transthyretin amyloidosis. Ann Med. 2015;47(8):625\u201338. https:\/\/doi.org\/10.3109\/07853890.2015.1068949.","journal-title":"Ann Med"},{"issue":"1","key":"183_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1185\/03007995.2012.754348","volume":"29","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maurer MS, Suhr OB. THAOS\u2014the transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin. 2013;29(1):63\u201376. https:\/\/doi.org\/10.1185\/03007995.2012.754348.","journal-title":"Curr Med Res Opin"},{"key":"183_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26034","author":"HH Schmidt","year":"2017","unstructured":"Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2017. https:\/\/doi.org\/10.1002\/mus.26034.","journal-title":"Muscle Nerve"},{"issue":"4","key":"183_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3109\/13506129.2012.712925","volume":"19","author":"A Gonzalez-Duarte","year":"2012","unstructured":"Gonzalez-Duarte A, Soto KC, Martinez-Banos D, et al. Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation. Amyloid. 2012;19(4):171\u20136. https:\/\/doi.org\/10.3109\/13506129.2012.712925.","journal-title":"Amyloid"},{"issue":"1","key":"183_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13023-019-1000-1","volume":"14","author":"M Waddington-Cruz","year":"2019","unstructured":"Waddington-Cruz M, Schmidt H, Botteman MF, et al. Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series. Orphanet J Rare Dis. 2019;14(1):34. https:\/\/doi.org\/10.1186\/s13023-019-1000-1.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"183_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/mus.23901","volume":"49","author":"I Conceicao","year":"2014","unstructured":"Conceicao I, Costa J, Castro J, de Carvalho M. Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy. Muscle Nerve. 2014;49(2):181\u20136. https:\/\/doi.org\/10.1002\/mus.23901.","journal-title":"Muscle Nerve"},{"issue":"2","key":"183_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3109\/13506129.2011.565524","volume":"18","author":"H Koike","year":"2011","unstructured":"Koike H, Hashimoto R, Tomita M, et al. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid. 2011;18(2):53\u201362. https:\/\/doi.org\/10.3109\/13506129.2011.565524.","journal-title":"Amyloid"},{"issue":"2","key":"183_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1097\/TP.0000000000001021","volume":"100","author":"OB Suhr","year":"2016","unstructured":"Suhr OB, Larsson M, Ericzon B-G, Wilczek HE. Survival after transplantation in patients with mutations other than Val30Met: extracts from the FAP world transplant registry. Transplantation. 2016;100(2):373\u201381. https:\/\/doi.org\/10.1097\/TP.0000000000001021.","journal-title":"Transplantation"},{"issue":"11","key":"183_CR12","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","volume":"260","author":"T Coelho","year":"2013","unstructured":"Coelho T, Maia LF, da Silva AM, et al. Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy. J Neurol. 2013;260(11):2802\u201314. https:\/\/doi.org\/10.1007\/s00415-013-7051-7.","journal-title":"J Neurol"},{"issue":"1","key":"183_CR13","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01.TP.0000092307.98347.CB","volume":"77","author":"G Herlenius","year":"2004","unstructured":"Herlenius G, Wilczek HE, Larsson M, Ericzon B-G. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry. Transplantation. 2004;77(1):64\u201371. https:\/\/doi.org\/10.1097\/01.TP.0000092307.98347.CB.","journal-title":"Transplantation"},{"key":"183_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/nrcardio.2010.67","volume":"7","author":"C Rapezzi","year":"2010","unstructured":"Rapezzi C, Quarta CC, Riva L, et al. Transthyretin-related amyloidoses and the heart: a clinical overview. Nat Rev Cardiol. 2010;7:398. https:\/\/doi.org\/10.1038\/nrcardio.2010.67.","journal-title":"Nat Rev Cardiol"},{"key":"183_CR15","volume-title":"Clinical practice guideline process manual","author":"American Academy of Neurology","year":"2011","unstructured":"American Academy of Neurology. Clinical practice guideline process manual. St. Paul: American Academy of Neurology; 2011."},{"key":"183_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol. 2012;12:9. https:\/\/doi.org\/10.1186\/1471-2288-12-9.","journal-title":"BMC Med Res Methodol"},{"issue":"178","key":"183_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1126\/scitranslmed.3004018","volume":"5","author":"EL Korn","year":"2013","unstructured":"Korn EL, McShane LM, Freidlin B. Statistical challenges in the evaluation of treatments for small patient populations. Sci Transl Med. 2013;5(178):178. https:\/\/doi.org\/10.1126\/scitranslmed.3004018.","journal-title":"Sci Transl Med."},{"issue":"1","key":"183_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s13023-018-0851-1","volume":"13","author":"K Tingley","year":"2018","unstructured":"Tingley K, Coyle D, Graham ID, et al. Using a meta-narrative literature review and focus groups with key stakeholders to identify perceived challenges and solutions for generating robust evidence on the effectiveness of treatments for rare diseases. Orphanet J Rare Dis. 2018;13(1):104. https:\/\/doi.org\/10.1186\/s13023-018-0851-1.","journal-title":"Orphanet J Rare Dis."},{"issue":"7","key":"183_CR19","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","volume":"123","author":"D Adams","year":"2000","unstructured":"Adams D, Samuel D, Goulon-Goeau C, et al. The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain. 2000;123(7):1495\u2013504.","journal-title":"Brain"},{"issue":"1","key":"183_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1716153","volume":"379","author":"D Adams","year":"2018","unstructured":"Adams D, Gonzalez-Duarte A, O\u2019Riordan WD, et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N Engl J Med. 2018;379(1):11\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1716153.","journal-title":"N Engl J Med"},{"issue":"19","key":"183_CR21","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1016\/j.jacc.2015.08.870","volume":"66","author":"V Algalarrondo","year":"2015","unstructured":"Algalarrondo V, Antonini T, Theaudin M, et al. Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis. J Am Coll Cardiol. 2015;66(19):2154\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2015.08.870.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"183_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/13506129.2013.845745","volume":"20","author":"AM Arruda-Olson","year":"2013","unstructured":"Arruda-Olson AM, Zeldenrust SR, Dispenzieri A, et al. Genotype, echocardiography, and survival in familial transthyretin amyloidosis. Amyloid. 2013;20(4):263\u20138. https:\/\/doi.org\/10.3109\/13506129.2013.845745.","journal-title":"Amyloid"},{"issue":"3","key":"183_CR23","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1080\/13506129.2017.1357545","volume":"24","author":"FA Barroso","year":"2017","unstructured":"Barroso FA, Judge DP, Ebede B, et al. Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years. Amyloid. 2017;24(3):194\u2013204. https:\/\/doi.org\/10.1080\/13506129.2017.1357545.","journal-title":"Amyloid"},{"issue":"1","key":"183_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1053\/jlts.2002.29764","volume":"8","author":"PL Bittencourt","year":"2002","unstructured":"Bittencourt PL, Couto CA, Farias AQ, Marchiori P, Bosco Massarollo PC, Mies S. Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil. Liver Transpl. 2002;8(1):34\u20139. https:\/\/doi.org\/10.1053\/jlts.2002.29764.","journal-title":"Liver Transpl"},{"issue":"2","key":"183_CR25","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3109\/13506120208995245","volume":"9","author":"M de Carvalho","year":"2002","unstructured":"de Carvalho M, Conceicao I, Bentes C, Luis MLS. Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid. 2002;9(2):126\u201333.","journal-title":"Amyloid"},{"issue":"21","key":"183_CR26","doi-asserted-by":"publisher","first-page":"e1999","DOI":"10.1212\/wnl.0000000000006543","volume":"91","author":"T Coelho","year":"2018","unstructured":"Coelho T, In\u00eas M, Concei\u00e7\u00e3o I, Soares M, de Carvalho M, Costa J. Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy. Neurology. 2018;91(21):e1999. https:\/\/doi.org\/10.1212\/wnl.0000000000006543.","journal-title":"Neurology."},{"issue":"5","key":"183_CR27","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","volume":"6","author":"MCA Coutinho","year":"2013","unstructured":"Coutinho MCA, Cortez-Dias N, Cantinho G, et al. Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging. 2013;6(5):627\u201336. https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.000367.","journal-title":"Circ Cardiovasc Imaging"},{"issue":"9","key":"183_CR28","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1097\/TP.0000000000000574","volume":"99","author":"B-G Ericzon","year":"2015","unstructured":"Ericzon B-G, Wilczek HE, Larsson M, et al. Liver transplantation for hereditary transthyretin amyloidosis: after 20 years still the best therapeutic alternative? Transplantation. 2015;99(9):1847\u201354. https:\/\/doi.org\/10.1097\/TP.0000000000000574.","journal-title":"Transplantation"},{"issue":"Suppl 2","key":"183_CR29","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ctr.12193","volume":"27","author":"C Franz","year":"2013","unstructured":"Franz C, Hoffmann K, Hinz U, et al. Modified body mass index and time interval between diagnosis and operation affect survival after liver transplantation for hereditary amyloidosis: a single-center analysis. Clin Transplant. 2013;27 Suppl 2:40\u20138. https:\/\/doi.org\/10.1111\/ctr.12193.","journal-title":"Clin Transplant"},{"key":"183_CR30","unstructured":"Gonz\u00e1lez-L\u00f3pez E, Laura L, Mar\u00edn G\u00f3mez LM, et al. Liver transplantation for hereditary transthyretin amyloidosis (hATTR) in Spain\u201425-year experience. In: Paper presented at the 16th international symposium on Amyloidosis. Kumamoto, Japan. 2018."},{"key":"183_CR31","unstructured":"In\u00eas M, Coelho T, Concei\u00e7\u00e3o I, Soares M, Carvalho M, Costa J. Clinical paradigms in treatment effectiveness for hereditary transthyretin amyloidosis. In: Paper presented at the 16th international symposium on Amyloidosis. Kumamoto, Japan. 2018."},{"issue":"5","key":"183_CR32","doi-asserted-by":"publisher","first-page":"e96324","DOI":"10.1371\/journal.pone.0096324","volume":"9","author":"T Kawaji","year":"2014","unstructured":"Kawaji T, Inoue T, Hara R, Eiki D, Ando Y, Tanihara H. Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy. PLoS One. 2014;9(5):e96324. https:\/\/doi.org\/10.1371\/journal.pone.0096324.","journal-title":"PLoS One"},{"issue":"6","key":"183_CR33","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.transproceed.2016.04.020","volume":"48","author":"F Lagarto","year":"2016","unstructured":"Lagarto F, Gomes B, Couto PS, et al. Perioperative predictors of survival after liver transplantation for familial amyloid polyneuropathy in a Portuguese Center. Transplant Proc. 2016;48(6):2098\u2013101. https:\/\/doi.org\/10.1016\/j.transproceed.2016.04.020.","journal-title":"Transplant Proc."},{"issue":"3","key":"183_CR34","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ana.24725","volume":"80","author":"AJ Loavenbruck","year":"2016","unstructured":"Loavenbruck AJ, Singer W, Mauermann ML, et al. Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox? Ann Neurol. 2016;80(3):401\u201311. https:\/\/doi.org\/10.1002\/ana.24725.","journal-title":"Ann Neurol"},{"issue":"1","key":"183_CR35","first-page":"27","volume":"11","author":"L Lobato","year":"2004","unstructured":"Lobato L, Beirao I, Silva M, et al. End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors. Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis. 2004;11(1):27\u201337.","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis."},{"issue":"6","key":"183_CR36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ana.24519","volume":"78","author":"L-L Mariani","year":"2015","unstructured":"Mariani L-L, Lozeron P, Theaudin M, et al. Genotype\u2013phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France. Ann Neurol. 2015;78(6):901\u201316. https:\/\/doi.org\/10.1002\/ana.24519.","journal-title":"Ann Neurol"},{"issue":"1","key":"183_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13506120500032741","volume":"12","author":"M Munar-Ques","year":"2005","unstructured":"Munar-Ques M, Saraiva MJM, Viader-Farre C, Zabay-Becerril JM, Mulet-Ferrer J. Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain). Amyloid. 2005;12(1):54\u201361. https:\/\/doi.org\/10.1080\/13506120500032741.","journal-title":"Amyloid"},{"issue":"9","key":"183_CR38","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s00595-010-4488-5","volume":"41","author":"Y Ohya","year":"2011","unstructured":"Ohya Y, Okamoto S, Tasaki M, et al. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation. Surg Today. 2011;41(9):1211\u20138. https:\/\/doi.org\/10.1007\/s00595-010-4488-5.","journal-title":"Surg Today"},{"issue":"2","key":"183_CR39","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/lt.22184","volume":"17","author":"S Okamoto","year":"2011","unstructured":"Okamoto S, Hornsten R, Obayashi K, Wijayatunga P, Suhr OB. Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant). Liver Transpl. 2011;17(2):122\u20138. https:\/\/doi.org\/10.1002\/lt.22184.","journal-title":"Liver Transpl"},{"issue":"10","key":"183_CR40","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1002\/lt.21817","volume":"15","author":"S Okamoto","year":"2009","unstructured":"Okamoto S, Wixner J, Obayashi K, et al. Liver transplantation for familial amyloidotic polyneuropathy: impact on Swedish patients\u2019 survival. Liver Transpl. 2009;15(10):1229\u201335. https:\/\/doi.org\/10.1002\/lt.21817.","journal-title":"Liver Transpl"},{"issue":"1","key":"183_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/13506129.2015.1123149","volume":"23","author":"K Okumura","year":"2016","unstructured":"Okumura K, Yamashita T, Masuda T, et al. Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation. Amyloid. 2016;23(1):39\u201345. https:\/\/doi.org\/10.3109\/13506129.2015.1123149.","journal-title":"Amyloid"},{"issue":"3","key":"183_CR42","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1212\/WNL.51.3.708","volume":"51","author":"V Plante-Bordeneuve","year":"1998","unstructured":"Plante-Bordeneuve V, Lalu T, Misrahi M, et al. Genotypic-phenotypic variations in a series of 65 patients with familial amyloid polyneuropathy. Neurology. 1998;51(3):708\u201314.","journal-title":"Neurology"},{"issue":"9","key":"183_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1053\/jlts.2002.34386","volume":"8","author":"OB Suhr","year":"2002","unstructured":"Suhr OB, Ericzon B-G, Friman S. Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type). Liver Transpl. 2002;8(9):787\u201394. https:\/\/doi.org\/10.1053\/jlts.2002.34386.","journal-title":"Liver Transpl"},{"issue":"2","key":"183_CR44","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3109\/13506129.2015.1019610","volume":"22","author":"PL Swiecicki","year":"2015","unstructured":"Swiecicki PL, Zhen DB, Mauermann ML, et al. Hereditary ATTR amyloidosis: a single-institution experience with 266 patients. Amyloid. 2015;22(2):123\u201331. https:\/\/doi.org\/10.3109\/13506129.2015.1019610.","journal-title":"Amyloid"},{"issue":"11","key":"183_CR45","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.2169\/internalmedicine.44.1151","volume":"44","author":"Y-I Takei","year":"2005","unstructured":"Takei Y-I, Ikeda S-I, Ikegami T, Hashikura Y, Miyagawa S-I, Ando Y. Ten years of experience with liver transplantation for familial amyloid polyneuropathy in Japan: outcomes of living donor liver transplantations. Intern Med. 2005;44(11):1151\u20136.","journal-title":"Intern Med"},{"issue":"2","key":"183_CR46","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3109\/13506129909007313","volume":"6","author":"K Tashima","year":"1999","unstructured":"Tashima K, Suhr OB, Ando Y, et al. Gastrointestinal dysfunction in familial amyloidotic polyneuropathy (ATTR Val30Met)\u2013comparison of Swedish and Japanese patients. Amyloid. 1999;6(2):124\u20139.","journal-title":"Amyloid."},{"key":"183_CR47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12876-015-0284-4","volume":"15","author":"J Wixner","year":"2015","unstructured":"Wixner J, Sundstrom T, Karling P, Anan I, Suhr OB. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. BMC Gastroenterol. 2015;15:51. https:\/\/doi.org\/10.1186\/s12876-015-0284-4.","journal-title":"BMC Gastroenterol"},{"issue":"1","key":"183_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jmg.35.1.23","volume":"35","author":"K Yamamoto","year":"1998","unstructured":"Yamamoto K, Ikeda S, Hanyu N, Takeda S, Yanagisawa N. A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. J Med Genet. 1998;35(1):23\u201330.","journal-title":"J Med Genet"},{"issue":"11","key":"183_CR49","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1111\/j.1600-6143.2007.01969.x","volume":"7","author":"S Yamamoto","year":"2007","unstructured":"Yamamoto S, Wilczek HE, Nowak G, et al. Liver transplantation for familial amyloidotic polyneuropathy (FAP): a single-center experience over 16 years. Am J Transplant. 2007;7(11):2597\u2013604. https:\/\/doi.org\/10.1111\/j.1600-6143.2007.01969.x.","journal-title":"Am J Transplant"},{"issue":"9","key":"183_CR50","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","volume":"78","author":"T Yamashita","year":"2012","unstructured":"Yamashita T, Ando Y, Okamoto S, et al. Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy. Neurology. 2012;78(9):637\u201343. https:\/\/doi.org\/10.1212\/WNL.0b013e318248df18.","journal-title":"Neurology."},{"issue":"1","key":"183_CR51","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","volume":"265","author":"T Yamashita","year":"2018","unstructured":"Yamashita T, Ueda M, Misumi Y, et al. Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan. J Neurol. 2018;265(1):134\u201340. https:\/\/doi.org\/10.1007\/s00415-017-8640-7.","journal-title":"J Neurol"},{"issue":"3","key":"183_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/13506120802193720","volume":"15","author":"U Hellman","year":"2008","unstructured":"Hellman U, Alarcon F, Lundgren H-E, Suhr OB, Bonaiti-Pellie C, Plante-Bordeneuve V. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Amyloid. 2008;15(3):181\u20136. https:\/\/doi.org\/10.1080\/13506120802193720.","journal-title":"Amyloid"},{"issue":"3","key":"183_CR53","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/lt.24058","volume":"21","author":"A Carvalho","year":"2015","unstructured":"Carvalho A, Rocha A, Lobato L. Liver transplantation in transthyretin amyloidosis: issues and challenges. Liver Transpl. 2015;21(3):282\u201392. https:\/\/doi.org\/10.1002\/lt.24058.","journal-title":"Liver Transpl"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-020-00183-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-020-00183-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T11:32:14Z","timestamp":1712835134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-020-00183-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,31]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["183"],"URL":"https:\/\/doi.org\/10.1007\/s40120-020-00183-7","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,31]]},"assertion":[{"value":"12 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}